Author

Moira Verbelen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Genetics· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1

Frequent Co-Authors

Cathryn M Lewis· 2 shared Dan Cohen· 1 shared David A Collier· 1 shared James H MacCabe· 1 shared Michael E Weale· 1 shared

Activity by Year

2014-2016 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 7 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenetics

Cathryn M Lewis

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GeneticsbioRxivJul 23, 2016

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?

Moira Verbelen, Michael E Weale, Cathryn M Lewis

This study reviews economic evaluations of pharmacogenetic-guided treatments and finds that cost-effectiveness improves significantly if genetic testing is free.

DOI 10.1038/tpj.2017.21

statistical modelbenchmarking

𝕏 PostBluesky

GeneticsbioRxivOct 31, 2014

Establishing the characteristics of an effective pharmacogenetic test for clozapine induced agranulocytosis

Moira Verbelen, David A Collier, Dan Cohen…·Cathryn M Lewis

This paper explores the relationship between pharmacogenetic test sensitivity, patient stratification, and agranulocytosis risk to improve clozapine safety.

DOI 10.1038/tpj.2015.5

humanstatistical model

𝕏 PostBluesky